Fundraising Fox
/Companies
Sign in

AccuVein

Cold Spring Harbor, US · Delaware corporation · 2 known investors

Find your way into AccuVein

Sign up to see every warm intro you have to AccuVein

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the AccuVein team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

AccuVein manufactures vein visualization systems for medical professionals to locate veins during procedures. The company serves healthcare providers in clinical and procedural settings.

HardwareHealthtechMedical Devices

Founders & leadership

RGRon Goldman
Ron GoldmanCEO & President2007–2020
CHChris Hutchison
Chris HutchisonPresident & CEOChris Hutchison is President and CEO of AccuVein, which manufactures vein visualization systems for medical professionals. He has held general management positions with international scope across the U.S., Europe, and emerging markets, including leading large-scale divestiture and integration projects.

Board

JL
James LackieBoard director
EBEric Bednarski
Eric BednarskiBoard directorPartner at MVM Life Science Partners
FF
Frank Flaut IIIBoard director
CG
Christopher GabrieliBoard director

Investors · 2

MVM Life Science PartnersreportedLondon · $20M – $100Mvia Stephen Reeders · board

How we know: board seat on SEC Form D · funding news · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$40.5M disclosed across 7 rounds · 2016–2023

▶$5.3MraisedFeb 2023 · 25 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Heather RohanDirector
  • Brian VerrierDirector
  • Kevin McArdleExecutive Officer
  • Christopher HutchisonExecutive Officer, Director
  • Akhilesh PathipatiDirector
  • Stephen ReedersDirector
  • James LackieDirector
Offering amount
$5.4M
Amount sold
$5.3M
First sale
Jan 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$17.3MraisedApr 2022 · 36 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Akhilesh PathipatiDirector
  • Brian VerrierDirector
  • Stephen ReedersDirector
  • James LackieDirector
  • Christopher HutchisonExecutive Officer, Director
  • Heather RohanDirector
  • Kevin McArdleExecutive Officer
Offering amount
$18.3M
Amount sold
$17.3M
First sale
Jul 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedMay 2020 · 33 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Chuck JohnsonExecutive Officer
  • James LackieDirector
  • Christopher GabrieliDirector
  • Rudy MazzochiDirector
  • Ron GoldmanExecutive Officer, Director
  • Hugo HarrodDirector
Offering amount
$2.5M
Amount sold
$2.5M
First sale
Apr 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedNov 2019 · 33 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher GabrieliDirector
  • Chuck JohnsonExecutive Officer
  • Ron GoldmanExecutive Officer, Director
  • James LackieDirector
  • Rudy MazzochiDirector
  • Hugo HarrodDirector
Offering amount
$2.1M
Amount sold
$2M
First sale
Oct 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8MraisedFeb 2018 · 40 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Hugo HarrodDirector
  • Christopher GabrieliDirector
  • James LackieDirector
  • Ron GoldmanExecutive Officer, Director
Offering amount
$10M
Amount sold
$8M
First sale
Jan 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.9MraisedJan 2018 · 11 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • James LackieDirector
  • Ron GoldmanExecutive Officer, Director
  • Frank Flaunt IIIDirector
  • Christopher GabrieliDirector
  • Hugo HarrodDirector
Offering amount
$2.9M
Amount sold
$2.9M
First sale
Sep 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedDec 2016 · 28 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • James LackieDirector
  • Eric BednarskiDirector
  • Frank Flaut IIIDirector
  • Ron GoldmanExecutive Officer, Director
  • Christopher GabrieliDirector
Offering amount
$9.1M
Amount sold
$2.5M
First sale
Nov 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

ivWatchivWatch develops sensors and monitoring systems that detect peripheral IV infiltrations and extravasations at early stages to prevent patient harm in hospital settings. The company serves healthcare providers and hospitals globally through direct partnerships and a network of distributors.

Companies working in the same space as AccuVein.

Frequently asked questions

What does AccuVein do?
AccuVein manufactures vein visualization systems for medical professionals to locate veins during procedures. The company serves healthcare providers in clinical and procedural settings.
Who are AccuVein's investors?
AccuVein's investors include Bessemer Venture Partners, MVM Life Science Partners.
How much funding has AccuVein raised?
AccuVein has disclosed $40.5M raised across 7 rounds.
Where is AccuVein headquartered?
AccuVein is headquartered in Cold Spring Harbor, US.